J Biol Chem 232:10771091 Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, Ali S, Kim M, Kabir MG, Seino Y, Suzuki J, Drucker DJ (2018) Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction
Your best bet for a personalized protein target is to work with your PCP or a dietitian
Retatrutide is still in clinical evaluation, and long-term data on combined use with MOTS-c is limited
Lets delve into the science behind NAD+ and its potential to redefine the aging process
The medication works in the following ways: It binds to GLP-1 receptors to stimulate insulin secretion from pancreatic beta cells